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The effects of the alkaloid-rich fraction of Himatanthus lancifolius (Müll. Arg) Woodson on normal 
marrow cells and leukemic cell lines were investigated. After 48 h exposure, the proliferation assay 
showed significant cell growth inhibition for Daudi (0.1-10 µg/mL), K-562 (1-10 µg/mL), and REH 
cells (10-100 µg/mL), yet was inert for normal marrow cells. A similar inhibition profile was observed 
in clonogenic assays. This alkaloid-rich fraction, in which uleine is the main compound, showed no 
signs of toxicity to any cells up to 10 µg/mL. Cell feature analyses after induction of differentiation 
showed maintenance of the initial phenotype. Flow cytometric expression of Annexin-V and 7-AAD in 
K-562 and Daudi cells has indicated that the cells were not undergoing apoptosis or necrosis, suggesting 
cytostatic activity for tumor cells.
Uniterms: Apocynaceae. Cell proliferation. Himatanthus lancifolius. Indole alkaloids. Leukemia. Plant 
extract.
Os efeitos da fração rica em alcalóides indólicos de Himatanthus lancifolius (Müll. Arg) Woodson sobre 
células normais de medula óssea e linhagens celulares leucêmicas foram investigados. Após 48 horas de 
exposição, os ensaios de proliferação demonstraram efeitos inibitórios significativos para as linhagens 
Daudi (0,1-10 µg/mL), K-562 (1-10 µg/mL) e REH (10-100 µg/mL), enquanto mostrou-se inerte sobre 
células normais de medula óssea. Os perfis de inibição se repetiram nos ensaios clonogênicos. A fração 
rica em alcalóides, na qual a uleína é a substância majoritária, não demonstrou toxicidade até a dose de 
10 µg/mL para nenhuma das células incluídas no estudo. Da mesma forma, não se observou influência 
dessa fração sobre a diferenciação celular dessas linhagens, mas manutenção de seu estado maturacional 
inicial. O conjunto de dados descritos associado à baixa co-expressão de anexina-V e 7-AAD sugerem 
que esta fração exerce atividade citostática para células tumorais.
Unitermos: Apocynaceae. Proliferação celular. Himatanthus lancifolius/farmacognosia. Alcalóides 
indólicos. Leucemia. Extrato vegetal.
INTRODUCTION
The hematopoietic system functions throughout 
the life of the animal to continually supply the mature 
cells of the myeloid and lymphoid lineages derived from 
the hematopoietic stem cells by a hierarchical system of 
progenitors with varying capacities for cell replication 
and increasing differentiation potentialities. These actions 
can be monitored by assays that are based on the ability of 
progenitor cells to proliferate in vitro in response to growth 
factors and cytokines, as occurs physiologically in vivo.
Leukemia is a broad term covering a spectrum of 
malignancies of the hematopoietic system causing high 
death rates worldwide. In Brazil alone, according to the 
National Institute of Cancer (INCA), around ten thousand 
new cases were expected for 2008, accounting for nearly 
3% of the total number of new diagnosed neoplasms. 
They are clinically and pathologically split into acute and 
chronic forms, characterized by an increase in immature 
blood cells or an excessive build up of relatively mature 
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but abnormal cells, respectively. Whatever is the case, the 
malignant cell crowding renders the bone marrow unable 
to produce healthy blood cells to aid body metabolism 
against anemia, infections, or coagulation disorders.
Given its nature, leukemia continues to present for-
midable treatment challenges as there is not yet a “standard 
approach” that reliably and safely cures the majority of 
patients suffering from these disorders. A considerable 
portion of anti-tumor agents currently used in the clinic 
are of natural origin. In fact, half of all anti-cancer drugs 
approved internationally between the 1940s and 2006 
were either natural products or their derivatives and were 
developed on the basis of knowledge gained from small 
molecules or macromolecules that exist in nature (Efferth 
et al., 2007).
Naturally occurring drugs that are part of the arsenal 
in the war against cancer include several indole Vinca al-
kaloids (vincristine, vinblastine, vindesine, vinorelbine), 
taxanes (paclitaxel, docetaxel), podophyllotoxin and its 
derivatives (etoposide, teniposide), camptothecin and its 
derivatives (topothecan, irinothecan), and anthracyclines 
(doxorubicin, daunorubicin, epirubicin, idarubicin) 
amongst others.
Plants of the genus Himatanthus (Apocynaceae) 
are used in South American folk medicine for several 
conditions ranging from snakebites, tumors, arthritis to 
gastritis. Activities against malaria (Milliken, 1997), cu-
taneous leishmaniasis, and trypanosomiasis (Castillo et 
al., 2007) have been reported as well as anti-inflammatory 
and analgesic properties (Miranda et al., 2000; Vanderlei, 
Souzabrito, 1986).
Himatanthus lancifolius (Muell. Arg.) Woodson 
is a plant widely distributed in Brazil and officially de-
scribed in the Brazilian Pharmacopoeia I (Santos, 1926). 
Popularly known as “agoniada”, its dried stem barks are 
used in folk medicine for treating ulcers, skin conditions, 
as a febrifuge, emmenagogue, purgative, against asthma, 
syphilis, for regularizing menstrual cycles, and also for 
coping with conception by stimulating uterine contractions 
(Corrêa et al., 1998).
Many activities for the alkaloid-rich fraction (ARF) 
obtained from the H. lancifolius barks, rich in indole 
alkaloids such as uleine and demethoxyaspidospermine 
(França et al., 2000), have been reported. First, it has dem-
onstrated a broad-spectrum of in vitro antimicrobial activ-
ity for pathogenic microorganisms (Souza et al., 2004). A 
gastroprotective effect of this fraction has been described 
(Baggio et al., 2005), supporting the popular usage of the 
plant as an anti-ulcer agent. In addition, this fraction was 
able to alter vascular and non-vascular smooth muscle 
responsiveness (Rattmann et al., 2005). Recently, we 
have shown that uleine, its major alkaloid component, 
was able to interfere with human leukocyte functions as 
it significantly inhibited the migration of casein-induced 
granulocytes and their adhesion to fibronectin and vitro-
nectin, confirming its usefulness in inflammatory condi-
tions (Nardin et al., 2008).
As some indole alkaloids recently isolated have 
shown antileukemic effects (Gan et al., 2006; Zhang et al., 
2007), the aim of this study was to investigate the effects 
of ARF extracted from H. lancifolius barks on normal and 
leukemic cells. In the present study, we describe for the 
first time that this fraction possesses a cytostatic action 
restricted to leukemic cells.
MATERIAL AND METHODS
Plant Material
Himatanthus lancifolius (Muell. Arg.) Woodson 
stem barks were purchased in the city of São Paulo, Brazil, 
in February 2003, and identified according to the Brazilian 
Pharmacopoeia I description (Santos, 1926), and by macro 
and microscopic comparisons with an authentic sample 
of the Laboratory of Pharmacognosy, Department of 
Pharmacy, Federal University of Paraná, Curitiba, Brazil, 
which holds a voucher specimen deposited under Protocol 
No. HLF-9.
Alkaloid-rich fraction and treatment solution
The procedures undertaken for obtaining the alka-
loid-rich fraction along with its chemical characterization 
have been essentially described elsewhere (Baggio et al., 
2005; Rattmann et al., 2005; Nardin et al., 2008). ARF sto-
ck solution at 1 mg/mL was prepared by diluting it directly 
into RPMI 1640 (Himedia Laboratories; Mumbal, India) 
or IMDM (Gibco; Paisley, UK) medium supplemented 
with inactivated-sterile fetal calf serum (FCS – Cultilab; 
Campinas, São Paulo, BR). After sterilization through 
a 0.22 um pore size filter, 1 mL aliquots were stored at 
minus 25 °C. Final concentrations (0.1 to 1000 µg/mL) 
were obtained by thawing and diluting the stock solution 
in the appropriate culture medium immediately prior to 
the experiments.
Cell lines
The K-562 and Daudi leukemia cell lines were pur-
chased from the Rio de Janeiro Cell Bank, Federal Uni-
versity of Rio de Janeiro (RJBC; Rio de Janeiro, Brazil). 
REH lymphoid cells were kindly provided by Dr. B. C. 
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Figueiredo, Centro de Genética Molecular e Pesquisa do 
Câncer em Crianças (CEGEMPAC; Curitiba, Brazil). The 
cell lines were kept at 37 °C in 5 % CO
2
 humidified atmos-
phere in RPMI 1640 medium supplemented with FCS (10 
and 20% for myeloid and for lymphoid cell lines, respecti-
vely), 2 mM L-glutamine (G-8540 Sigma; St Louis, MO, 
USA), 100 IU/mL G-penicillin (P-3032 Sigma; St Louis, 
MO, USA), 3 g/L sodium bicarbonate (S-5761 Sigma; St 
Louis, MO, USA) and 50 µg/mL streptomycin sulphate 
(S-6501 Sigma; St Louis, MO, USA). Twice a week, the 
cells were split at 105 cells/mL. REH cells were subcultured 
once a week at 105 cells/mL. For the experiments, all cell 
lines were harvested at the exponential growth phase and 
checked for viability using the Trypan blue assay [0.4% 
Trypan blue – 11732; Merck, Germany - in Dulbecco’s 
phosphate buffered saline (PBS)]. For the experiments, 
the number of viable cells always exceeded 95%.
Mouse bone marrow cells
The protocol used in this study for mouse bone 
marrow cells was previously approved by the Animal 
Experiment Ethics Committee of the Biological Scien-
ces Sector of the Federal University of Paraná (Proto-
col 23075.028831/2008-33). Bone marrow cells were 
obtained from femora and tibia of 4-5 week-old female 
C57/BL6 mice. The mononuclear fraction (MNC) was 
isolated from the interface using density gradient centri-
fugation on a Ficoll-PaqueTM PLUS device (Amersham 
Biosciences; Little Chalfont, UK). After washing twice 
with PBS, MNC was resuspended in IMDM supplemented 
with sodium bicarbonate, L-glutamine, 10 % fetal calf 
serum, and antibiotics as for RPMI 1640 medium.
Cell viability and toxicity
Toxic effects of the extract and all solutions used in 
this study on normal and leukemic cells were evaluated 
for all doses assayed using the trypan blue exclusion 
test. Viability was taken as the percentage of cells not 
incorporating the stain, counted in a hemocytometer 
after directly diluting the cell suspension with 0.4% 
Trypan blue solution. 
Proliferation assays
For each cell line, aliquots of 100 µL of cell suspen-
sions containing 105 cells in complete RMPI 1640 medium 
were distributed in flat-bottomed 96-well culture dishes 
(TPP; Switzerland) and left for 24 hours at 37 °C in a 
5% CO
2
 incubator. ARF solution was then added to give 
final concentrations ranging from 0.1 to 1000 µg/mL in a 
200 µL final volume/well for 48 hours. For bone marrow 
cells, a 100 µL containing 2x105 MNC in complete IMDM 
medium were seeded for each well and ARF was simul-
taneously added (0.1 to 1000 µg/mL) in a 200 µL final 
volume/well for a week. The number of cells recovered 
was evaluated on a hemocytometer. Each experiment was 
performed in triplicate and the results are expressed as 
the mean cell number recovered ± standard error of mean 
(SEM) after incubation of at least three independent ex-
periments, each one run in triplicate.
Differentiation assay
Hemin chloride 40 uM (H-5533 Sigma; St Louis, 
MO, USA) and theophylline 7 mM (T-1633 Sigma; St 
Louis, MO, USA) were used as positive differentiation 
inducers for K-562 (Huo et al., 2006) and Daudi (San-
dlund et al., 1993) cell lines, respectively. Triplicates of 
cell suspension of each cell line (106 cell/mL) in complete 
RMPI 1640 medium containing ARF solution to give final 
concentrations ranging from 0.1 to 100 µg/mL, or the re-
quired concentration of the cell differentiation inducers, 
in a 1000 µL final volume/well were distributed in 24-well 
culture plates (TPP; Switzerland) and incubated for 7 days 
at 37 °C in 5 % CO
2
. The morphology of the cultured cells 
was observed by immersion oil microscopy in cytospin 
preparations stained with May-Grunwald-Giemsa. Cell 
photos were documented using the Image Pro Plus sof-
tware, version 3.0.01.00 for Windows 3.0.
Colony-Forming assays
The clonogenic potential of K-562 cells was as-
sayed by counting colonies grown in the commercial 
viscous medium MethoCult™ (StemCell Technologies 
Inc.; Vancouver, CA) supplemented with Stem Cell Fac-
tor (50 ng/mL), GM-CSF (10 ng/mL), IL-3 (10 ng/mL), 
and erythropoietin (3 IU/mL) recombinant human cytoki-
nes. The cells were first washed with PBS, suspended in 
IMDM medium supplemented with 10 % FCS, and the 
concentration adjusted to a density of 2x105 cells/mL. 
103 K-562 cells were added to 1 mL of MethoCult. The 
mixture was plated in three aliquots of 0.3 mL each, 
into 24-well plastic culture dishes (TPP, Switzerland). 
For Daudi cells (104 cells/mL), the plating medium was 
composed of RPMI 1640 supplemented with 30 % of 
FCS, 10 % of Cariotype Medium (Cultilab; Campinas, 
BR) in a final volume of 3 mL plating mixture. A 150 µL 
volume of molten agar at 3.3% (A-9915 Sigma; St Lou-
is, MO, USA) was added to the mixture and 1 mL/dish 
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was immediately transferred to 40x11 mm plastic tissue 
culture Petri dishes (TPP, Switzerland). ARF (0.1-100 
µg/mL) was added to the plating medium immediately 
before the cells. The dishes were incubated at 37 °C in a 
fully humidified atmosphere supplemented with 5% CO
2
 
in air. After 7 days, the colonies were scored by direct 
observation under an inverted microscope. Each inde-
pendent experiment was performed in triplicate and the 
results are expressed as the mean colony number ± SEM.
Annexin-V and 7-AAD co-expression by flow 
cytometry
After 24 hours of subculture at 37 ˚C, K-562 and 
Daudi cells (106/mL) were treated with 10 or 100 µg/mL 
of ARF and further incubated for 48 hours. The cells were 
then harvested and washed with cold PBS by spinning at 
400 g for 5 min at 4 ˚C. Cells (105) were resuspended in 
100 �l of 1� binding buffer and stained with 2 �L An-
nexin V-FITC (BD/PharMingen; San Diego, California, 
USA) and 5 µL 7-aminoactinomycin D (7-AAD; BD/
PharMingen; San Diego, California, USA) in the dark for 
15 min at room temperature. Another 400 ul of 1� bind-
ing buffer were added at the end of staining period. Cells 
without exposure to the extract served as controls. In all 
experiments, fluorescence was measured using appropriate 
band pass filters for FITC (FLH-1) and 7-AAD (FLH-3) 
absorption in a BD FACS Calibur flow cytometer (Becton 
Dickinson; San Jose, California, USA) equipped with an 
argon laser tuned at 488 nm. For analyses, at least 104 
events were acquired in the gated populations. Data were 
analysed using the WinMDI 2.8 software, and the results 
are expressed as the mean percentage of positive cells for 
each population from three independent experiments.
Statistical analysis
Where applicable, significant differences (p≤0.05) 
between treated and control groups were determined using 
the Student’s t-test for comparison of two means, or Analy-
ses of Variance – one way (ANOVA) followed by Tukey’s 
HSD -a=0.05 for multiple comparisons.
RESULTS
Treatment of the cell lines with ARF at doses ran-
ging from 0.1 to 100 µg/mL for 48 hours after the setting 
period showed significant dose-dependent inhibition of 
cell growth for K-562, Daudi, and REH cells (Figure 1). 
No cells of any lineage could be recovered from cultures 
in which the final concentration of ARF was 1000 µg/mL.
The distinct proliferation behaviour of each cell line 
after ARF exposure may be better visualized in Figure 2. 
REH cells were the most affected, with an IC
50
 value of 
123.73 µg/mL, followed by Daudi (IC
50 
= 235.10 µg/mL) 
and K-562 cells (IC
50 
= 289.55 µg/mL). 
In contrast, ARF had little effect on normal marrow 
cell proliferation, for which the IC
50
 was 584.48 µg/mL. 
Interestingly and worthy of note, no cell toxicity of the 
ARF fraction was observed up to 10 µg/mL (Figure 3). In 
this frame, although a small but significant toxicity was ob-
served for the K-562, REH, and Daudi cells at 100 µg/mL, 
88.3±0.5, 86.5±2.8, and 79.8±2.6 % of the cells still remai-
ned viable, respectively (p<0.001 for all; n=3-5).
FIGURE 1 - Dose-dependent inhibition of H. lancifolius 
alkaloid-rich fraction in growth of leukemic and normal cells. 
Exponentially growing cells were treated with the indicated 
doses of ARF for 48 h, at 37 °C. Each bar represents the number 
of recovered cells±EPM from at least 3 experiments, each 
performed in triplicate. [#] p<0.05; [*] p<0.001.
FIGURE 2 – Effect of alkaloid-rich fraction of H. lancifolius 
on cell survival. The indicated cell lines were plated out in 
the presence of the H. lancifolius ARF. Each point represents 
the surviving fraction of leukemic cell lines recovered after 
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FIGURE 3 - Cytotoxic effects of H. lancifolius alkaloid-rich 
fraction on leukemic and normal cells. Cells in log phase were 
treated with the indicated doses of ARF for 48 h, at 37 °C. Each 
point represents the percentage of viable cells ± EPM recovered 
after trypan blue exposure from at least 3 experiments, each 
performed in triplicate. [*] p<0.001.
Because K-562 and Daudi cells are able to generate 
colonies in soft systems when appropriately stimulated, 
in order to investigate whether the inhibitory effect would 
affect the clonogenic response of these cells they were ex-
posed to ARF (0.1-100 µg/mL) for seven days at 37 °C and 
5% CO
2
. This resulted in significant concentration-de-
pendent inhibition of colony formation for both cell lines 
compared to the respective untreated populations (Figure 4).
For K-562 cells, the number of colonies declined 
from 176.6±13.3 (control) to 163.5±16.8 (p=0.025), 
138.8±12.1 (p≤0.05), and 105.3±2.0 (p≤0.001), respec-
FIGURE 4 - Inhibition of the clonogenic potential of leukemic 
cells by H. lancifolius alkaloid-rich fraction. Exponentially 
growing K-562 (103/mL) and Daudi cells (104/mL) were 
continuously exposed to increasing doses of ARF of H. 
lancifolius in soft-growing systems for 7 days at 37 °C and 5% 
CO
2
, as described in Materials and Methods. Each bar represents 
the mean ± EPM of colonies formed, scored under an inverted 
microscope. [#] p=0.025; [‡] p<0.05; [*] p<0.001.
tively at 0.1, 1 and 10 µg/mL (n=3). For Daudi cells, the 
values decreased from 120.5±7.8 (control) to 19.0±4.2, 
9.0±4.2, and 7.0±1.4 for the same dose range (p≤0.001). 
At 100 µg/mL, complete abrogation of colony formation 
response was observed for both cell lines. It is important 
to note that, although the number of colonies was affected, 
their size and morphology did not differ to those of the 
control experiments.
Cytospun preparations of the cultured cells after 
induction of differentiation showed no signs of damage 
or deterioration of either K-562 (Figure 5-A) or Daudi 
cells (Figure 5-B) but maintenance of their original pheno-
type, supporting not only the maintenance of the original 
phenotype but also their integrity. As small population 
presenting surface blebbing, denser cytoplasm, and nu-
clear well-delimited masses of various shapes and sizes 
of chromatin were observed (Figure 5, arrows in panels 
A and B), further experiments were conducted to clarify 
whether ARF would affect apoptosis in K-562 (Figure 
5-C) and Daudi cells. Flow cytometry analyses showed 
that less than 15% of the cells were positively labeled with 
Annexin-V and 7-AAD, suggesting that ARF does not 
induce apoptosis or necrosis, respectively, in these cells, 
confirming cell proliferation blocking.
DISCUSSION
Particularly as infusions, several plants have been 
used for the treatment of various diseases since ancient 
times and have gained recognition as biological response 
modifiers. A relevant concern is the detection of effects 
present in these infusions that may interfere with cell 
division. In this context, plants have been a source of 
clinically relevant anticancer compounds and nowadays 
many natural products and derivatives belong to the 
standard repertoire of cancer chemotherapy (Efferth et 
al., 2007). As an example, the compound homoharringto-
nine, isolated from Cephalotaxus species, has recently 
been reported to be among the most potent members of 
the antileukemia alkaloids (Quintás-Cardama, Cortes, 
2008). Therefore, the development of new agents able to 
impair leukemic cell growth is required to reduce not only 
the rate of mortality but also to provide ways for normal 
hematopoietic recovery.
Indole alkaloids isolated from a variety of medici-
nal plants have shown anti-leukemic effects (Gan et al., 
2006; Zhang et al., 2007). H. lancifolius is a Brazilian 
native plant that grows widely in several regions around 
the country and is rich in indole alkaloids. This prompted 
us to investigate the potential effects of its ARF on the in 
vitro growth of normal and leukemic cells.
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The proliferation assays showed that all leukemic cell 
lines included in this study responded to ARF in a similar 
fashion, independent of their lineage origin, with significant 
inhibition of their growth. In this context, the most relevant 
anti-proliferative activity was against REH and Daudi cells, 
both of lymphoid origin (Klein et al., 1968), followed by 
the K-562 cell line, which is a myeloid descendant (Lozzio 
et al., 1981). It is noteworthy that, because many anticancer 
agents are less cytocidal to quiescent cells than to actively 
proliferating cells, we only exposed proliferating cells to 
ARF to assure the effects would not rely upon quiescent 
cells. Although not proliferating, the leukemic cells were 
viable as defined by the trypan blue exclusion test. The 
anti-proliferative activity of ARF was further confirmed 
using the clonogenic survival assay, in which ARF influen-
ced the frequency of K562 and Daudi colonies, indicating 
that both short and long exposures to ARF were efficient 
FIGURE 5 - Alkaloid-rich fraction of H. lancifolius does not induce apoptosis in leukemic cells. K-562 and Daudi cells plated in 
RPMI 1640 at 37 °C for 24 h were treated with increasing doses (0.1-100 µg/mL) of ARF for 48 h. The morphology of the cultured 
cells was observed by immersion oil microscopy in cytospin preparations stained with May-Grunwald-Giemsa. The photos depict 
K-562 (A) and Daudi (B) cells after treatment with 10 µg/mL of ARF. Rare apoptotic figures were observed (arrows). Magnification: 
×1000. Panels in C show Annexin V and 7-AAD co-expression on K-562 cells after treatment with ARF, analyzed by flow cytometry.
in suppressing their growth response. Notably, along with 
proliferation tests, the in vitro colony-forming assays have 
been used for screening candidate compounds for potential 
hematotoxicity as it has proven to be a sensitive indicator of 
toxicity and have greater predictive value than conventional 
evaluations of peripheral blood cell counts and bone marrow 
cytology as a test for the hematotoxic potential of certain 
classes of compounds in humans (Parchment et al., 1993).
One of the factors regulating the population size of 
a clone of proliferating cells is the induction of a physio-
logical suicide mechanism known as apoptosis, a highly 
regulated process that occurs as part of differentiation, 
proliferation and growth of normal and malignant cells. 
Visualized by light microscopy, exposure of the cell lines 
included in this study, to increasing doses of ARF for 48 
hours did not induce differentiation. However, it did indu-
ce morphological changes characteristic of apoptosis but 
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only in a small population, which were confirmed by their 
low incorporation of Annexin-V. Thus, the data suggested 
that the H. lancifolius ARF was promoting a cytostatic 
rather than cytotoxic effect on these cell lines which was 
not observed for normal marrow cells.
Ex vivo maintenance and expansion of human primi-
tive hematopoietic cells has been a focus of current rese-
arch because it potentially involves clinical applications. 
The standard culture methods for this purpose rely on 
optimized combinations of cytokines. Although these con-
ditions provide some level of progenitor cell support, they 
primarily induce proliferation and differentiation, resulting 
in reduced repopulation capacity. The preliminary results 
presented in this study showed that the ARF prepared from 
the barks of H. lancifolius was able to inhibit the growth of 
some leukemic cell lines while preserving normal marrow 
cells. The anti-leukemic activity observed for ARF was 
not due to the induction of differentiation or apoptosis. In 
fact, our data showed that ARF had a significant cytostatic 
activity on these tumor cell lines.
There are several medicinal plants considered to pos-
sess significant anti-cancer activity, which have numerous 
bioactive compounds that contribute to these beneficial 
health effects. More recently, evidence is emerging that 
combinations of phytochemicals may be more effective in 
the war against cancer than isolated compounds. In fact, 
combinatorial effects have been observed (de Kok et al., 
2008) in which different and complementary modes of 
actions are involved (Kale et al., 2008; Moon et al., 2006). 
These activities can be attributed to their ability to interact 
with basic cellular mechanisms, including interference 
with membrane and intracellular receptors, modulation 
of signaling cascades, interaction with the basic enzymes 
involved in tumor promotion and metastasis, interaction 
with oncogenes and oncoproteins, and, finally, direct or 
indirect interactions with nucleic acids and nucleoproteins 
(Kampa et al., 2007).
Moreover, a variety of strategies are currently being 
considered for ex vivo elimination of neoplastic cells from 
autologous bone marrow grafts. The key objective inherent 
to these strategies is to effectively eliminate neoplastic cells 
while sparing the normal hematopoietic progenitor cells cru-
cial for engraftment. Therefore, the capacity of the H. lanci-
folius ARF fraction to preferentially inhibit the cell growth 
of leukemic cells makes it a candidate for further studies to 
clarify the mechanisms underlying these effects. This may 
prove important for ex vivo manipulation of human primi-
tive hematopoietic cells for clinical applications, extending 
the goal of cancer therapy to eradicating the affected cells (to 
control the cancer phenotype) while allowing the expansion 
of the normal hematopoietic population.
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